Literature DB >> 15664913

Evaluation of the role of the Bvg intermediate phase in Bordetella pertussis during experimental respiratory infection.

Nuria Vergara-Irigaray1, Alberto Chávarri-Martínez, Juan Rodríguez-Cuesta, Jeff F Miller, Peggy A Cotter, Guillermo Martínez de Tejada.   

Abstract

The BvgAS system of Bordetella pertussis was traditionally considered to mediate a transition between two phenotypic phases (Bvg(+) and Bvg(-)) in response to environmental signals. We characterized a third state, the intermediate (Bvg(i)) phase, which can be induced by introducing a 1-bp substitution into bvgS (the bvgS-I1 mutation) or by growing B. pertussis under conditions intermediate between those leading to the Bvg(+) and Bvg(-) phases. Like B. bronchiseptica, B. pertussis displays in its Bvg(i) phase a characteristic colony morphology and hemolytic activity and expresses a Bvg(i)-phase-specific polypeptide called BipA, whose synthesis is regulated by bvgAS at the transcriptional level. Based on our results, we hypothesize that the Bvg(i) phase of B. pertussis may be involved in facilitating transmission between hosts. Thus, a B. pertussis mutant carrying the bvgS-I1 mutation (GMT1i) persisted at wild-type levels only in the upper murine respiratory tract. Interestingly, a bipA deletion derivative of GMT1i displayed a reduced ability to colonize the nasal cavity of mice compared with GMT1i. However, in experimental mixed infections GMT1i expressing the Bvg(i) phase could establish an initial colonization in the nose and trachea of mice as efficiently as GMT1, but the wild-type strain outcompeted GMT1i at a later time point at all sites of the respiratory tract, suggesting that the Bvg(i) phase does not serve as a phenotypic phase specialized in colonization. Finally, even though B. pertussis expresses in vitro the Bvg(i) phase at the human nasal temperature, anti-BipA antibodies were undetectable in a large collection of sera from pertussis patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664913      PMCID: PMC547029          DOI: 10.1128/IAI.73.2.748-760.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Diversity in the Bordetella virulence regulon: transcriptional control of a Bvg-intermediate phase gene.

Authors:  R Deora; H J Bootsma; J F Miller; P A Cotter
Journal:  Mol Microbiol       Date:  2001-05       Impact factor: 3.501

2.  New virulence-activated and virulence-repressed genes identified by systematic gene inactivation and generation of transcriptional fusions in Bordetella pertussis.

Authors:  R Antoine; S Alonso; D Raze; L Coutte; S Lesjean; E Willery; C Locht; F Jacob-Dubuisson
Journal:  J Bacteriol       Date:  2000-10       Impact factor: 3.490

3.  Differential modulation of Bordetella pertussis virulence genes as evidenced by DNA microarray analysis.

Authors:  D Hot; R Antoine; G Renauld-Mongénie; V Caro; B Hennuy; E Levillain; L Huot; G Wittmann; D Poncet; F Jacob-Dubuisson; C Guyard; F Rimlinger; L Aujame; E Godfroid; N Guiso; M-J Quentin-Millet; Y Lemoine; C Locht
Journal:  Mol Genet Genomics       Date:  2003-05-24       Impact factor: 3.291

4.  Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica.

Authors:  Julian Parkhill; Mohammed Sebaihia; Andrew Preston; Lee D Murphy; Nicholas Thomson; David E Harris; Matthew T G Holden; Carol M Churcher; Stephen D Bentley; Karen L Mungall; Ana M Cerdeño-Tárraga; Louise Temple; Keith James; Barbara Harris; Michael A Quail; Mark Achtman; Rebecca Atkin; Steven Baker; David Basham; Nathalie Bason; Inna Cherevach; Tracey Chillingworth; Matthew Collins; Anne Cronin; Paul Davis; Jonathan Doggett; Theresa Feltwell; Arlette Goble; Nancy Hamlin; Heidi Hauser; Simon Holroyd; Kay Jagels; Sampsa Leather; Sharon Moule; Halina Norberczak; Susan O'Neil; Doug Ormond; Claire Price; Ester Rabbinowitsch; Simon Rutter; Mandy Sanders; David Saunders; Katherine Seeger; Sarah Sharp; Mark Simmonds; Jason Skelton; Robert Squares; Steven Squares; Kim Stevens; Louise Unwin; Sally Whitehead; Bart G Barrell; Duncan J Maskell
Journal:  Nat Genet       Date:  2003-08-10       Impact factor: 38.330

Review 5.  Phosphorelay control of virulence gene expression in Bordetella.

Authors:  Peggy A Cotter; Allison M Jones
Journal:  Trends Microbiol       Date:  2003-08       Impact factor: 17.079

6.  Antigenic modulation of Bordetella pertussis.

Authors:  B W LACEY
Journal:  J Hyg (Lond)       Date:  1960-03

7.  Pregenomic comparative analysis between bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection.

Authors:  E T Harvill; P A Cotter; J F Miller
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

8.  Modulation of host immune responses, induction of apoptosis and inhibition of NF-kappaB activation by the Bordetella type III secretion system.

Authors:  M H Yuk; E T Harvill; P A Cotter; J F Miller
Journal:  Mol Microbiol       Date:  2000-03       Impact factor: 3.501

9.  Identification and characterization of BipA, a Bordetella Bvg-intermediate phase protein.

Authors:  K E Stockbauer; B Fuchslocher; J F Miller; P A Cotter
Journal:  Mol Microbiol       Date:  2001-01       Impact factor: 3.501

10.  Comparison of bipA alleles within and across Bordetella species.

Authors:  Bryna Fuchslocher; Laura L Millar; Peggy A Cotter
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

View more
  18 in total

1.  Cross-species protection mediated by a Bordetella bronchiseptica strain lacking antigenic homologs present in acellular pertussis vaccines.

Authors:  Neelima Sukumar; Gina Parise Sloan; Matt S Conover; Cheraton F Love; Seema Mattoo; Nancy D Kock; Rajendar Deora
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

2.  Bordetella adenylate cyclase toxin interacts with filamentous haemagglutinin to inhibit biofilm formation in vitro.

Authors:  Casandra Hoffman; Joshua Eby; Mary Gray; F Heath Damron; Jeffrey Melvin; Peggy Cotter; Erik Hewlett
Journal:  Mol Microbiol       Date:  2016-11-03       Impact factor: 3.501

3.  Evidence for phenotypic bistability resulting from transcriptional interference of bvgAS in Bordetella bronchiseptica.

Authors:  Eliza Mason; Michael W Henderson; Erich V Scheller; Matthew S Byrd; Peggy A Cotter
Journal:  Mol Microbiol       Date:  2013-09-30       Impact factor: 3.501

4.  Functional genomics of stress response in Pseudomonas putida KT2440.

Authors:  Oleg N Reva; Christian Weinel; Miryam Weinel; Kerstin Böhm; Diana Stjepandic; Jörg D Hoheisel; Burkhard Tümmler
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

5.  Albumin, in the Presence of Calcium, Elicits a Massive Increase in Extracellular Bordetella Adenylate Cyclase Toxin.

Authors:  Laura A Gonyar; Mary C Gray; Gregory J Christianson; Borna Mehrad; Erik L Hewlett
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

6.  The First Siphoviridae Family Bacteriophages Infecting Bordetella bronchiseptica Isolated from Environment.

Authors:  Aleksandra Petrovic; Rok Kostanjsek; Gabor Rakhely; Petar Knezevic
Journal:  Microb Ecol       Date:  2016-09-15       Impact factor: 4.552

7.  Species- and strain-specific control of a complex, flexible regulon by Bordetella BvgAS.

Authors:  C A Cummings; H J Bootsma; D A Relman; J F Miller
Journal:  J Bacteriol       Date:  2006-03       Impact factor: 3.490

8.  The proinflammatory response induced by wild-type Yersinia pseudotuberculosis infection inhibits survival of yop mutants in the gastrointestinal tract and Peyer's patches.

Authors:  Lauren K Logsdon; Joan Mecsas
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

Review 9.  Integrated Signaling Pathways Mediate Bordetella Immunomodulation, Persistence, and Transmission.

Authors:  M C Gestal; L T Whitesides; E T Harvill
Journal:  Trends Microbiol       Date:  2018-10-27       Impact factor: 17.079

10.  Identification of a CO2 responsive regulon in Bordetella.

Authors:  Sara E Hester; Minghsun Lui; Tracy Nicholson; Daryl Nowacki; Eric T Harvill
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.